Author

Julie M Bracken

Centre for Cancer Biology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Katherine A. PillmaniD· 3 shared Cameron P. BrackeniD· 2 shared Philip A. GregoryiD· 2 shared Andrew G. BertiD· 1 shared Anupama PasamiD· 1 shared Ayla OrangiD· 1 shared B. Kate DredgeiD· 1 shared Briony L. GliddoniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Katherine A. PillmanORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Tumors Located in the Brain Impair the Frequency and Phenotype of Dendritic Cells in Blood and Tumor

Bryan Gardam, Tessa Gargett, Eunwoo Nam, Sidra Khan, Rebecca J. Ormsby, Santosh Isaac Poonnoose, Julie M Bracken, Anupama Pasam, Sakthi Lenin, Briony L. Gliddon, Melinda Nay Tea, Chloé Shard, Stuart Maxwell Pitson, Guillermo Alberto Gomez, Katherine A. Pillman, , Lisa M. Ebert

This paper identifies systemic reductions in dendritic cell (DC) numbers and activation markers in brain tumor patients, with brain tumors directly contributing to DC defects, and highlights corticosteroid use as a confounding factor.

iScience · Feb 26, 2026Peer-reviewedImmunology

Chasing non-existent microRNAs in cancer

Ayla Orang, Nicholas I. Warnock, Mélodie Migault, B. Kate Dredge, Andrew G. Bert, Julie M Bracken, Philip A. Gregory, Katherine A. Pillman, Gregory J. Goodall, Cameron P. Bracken

The paper investigates whether reported miRNAs in cancer are functionally active, finding many are not incorporated into RISC and lack endogenous silencing capability.

Oncogenesis · Apr 18, 2025Peer-reviewedCancer Biology

More than half of annotated human miRNAs are never expressed at levels sufficient for biological function

Saba Ataei Kachooei, Julie M Bracken, Katherine A. Pillman, Philip A. Gregory, Cameron P. Bracken

The paper shows that over half of annotated human miRNAs are not expressed at biologically significant levels, challenging the validity of many miRNA function studies.

bioRxiv · Dec 5, 2024 · PreprintMolecular Biology